Published in Clin Chim Acta on April 01, 2000
Biochemical markers of myocardial injury. Indian J Clin Biochem (2007) 0.83
Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators. N Engl J Med (1996) 5.94
Cardiac troponin T and cardiac troponin I: relative values in short-term risk stratification of patients with acute coronary syndromes. GUSTO-IIa Investigators. Clin Chem (1998) 2.27
Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa Investigators. Circulation (1998) 2.09
Removal of endotoxin from recombinant protein preparations. Clin Biochem (1997) 1.95
Temporal creatine kinase curves in acute myocardial infarction. Implications of a good empiric fit with the log-normal function. Am J Clin Pathol (1993) 1.75
Use of biochemical markers in acute coronary syndromes. IFCC Scientific Division, Committee on Standardization of Markers of Cardiac Damage. International Federation of Clinical Chemistry. Clin Chem Lab Med (1999) 1.70
Multicenter clinical and analytical evaluation of the AxSYM troponin-I immunoassay to assist in the diagnosis of myocardial infarction. Clin Chem (1999) 1.62
Characteristics of an Albumin Cobalt Binding Test for assessment of acute coronary syndrome patients: a multicenter study. Clin Chem (2001) 1.53
The use of neuronal networks on multielectrode arrays as biosensors. Biosens Bioelectron (1995) 1.41
Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion. J Am Coll Cardiol (2001) 1.22
Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin t-positive status: the paragon-B troponin T substudy. Circulation (2001) 1.07
Analysis of the Albumin Cobalt Binding (ACB) test as an adjunct to cardiac troponin I for the early detection of acute myocardial infarction. Cardiovasc Toxicol (2001) 1.05
Two radioassays for serum vitamin B12 and folate determination compared in a reference interval study. Clin Chem (1985) 1.04
Cardiac troponin I measurement with the ACCESS immunoassay system: analytical and clinical performance characteristics. Clin Chem (1998) 0.99
Analytical and clinical performance characteristics of Tandem-MP Ostase, a new immunoassay for serum bone alkaline phosphatase. Clin Chem (1998) 0.98
Issues in cerebrospinal fluid management. Acid-fast bacillus smear and culture. Am J Clin Pathol (1991) 0.96
Standardization of cardiac troponin I assays: round Robin of ten candidate reference materials. Clin Chem (2001) 0.94
Biochemical markers of the acute coronary syndromes. Clin Chem (1998) 0.91
Determinants of elevated blood lead levels among working men in Greater Beirut. J Med Liban (2002) 0.90
The focused review process: a utilization management firm's experience with length of stay guidelines. Jt Comm J Qual Improv (1995) 0.89
Cerebrospinal fluid (CSF) TRAP. A method to improve CSF laboratory efficiency. Am J Clin Pathol (1988) 0.88
Prodromal unstable angina in acute myocardial infarction: prognostic value of short- and long-term outcome and predictor of infarct size. Am Heart J (2000) 0.87
Cardiac markers: point of care testing. Clin Chim Acta (1999) 0.87
International survey on the use of cardiac markers. Clin Chem (2001) 0.87
Simultaneous rapid measurement of whole blood myoglobin, creatine kinase MB, and cardiac troponin I by the triage cardiac panel for detection of myocardial infarction. Clin Chem (1999) 0.86
Relation of temporal creatine kinase-MB release and outcome after thrombolytic therapy for acute myocardial infarction. TAMI Study Group. Am J Cardiol (2000) 0.85
Interpretation of cerebrospinal fluid protein assays in various neurologic diseases. Clin Chem (1983) 0.83
The case for cardiac troponin T: marker for effective risk stratification of patients with acute cardiac ischemia. Clin Chem (1996) 0.83
Noninvasive detection of reperfusion after thrombolysis based on serum creatine kinase MB changes and clinical variables. TAMI 7 Study Group. Thrombolysis and Angioplasty in Myocardial Infarction. Am Heart J (1993) 0.81
Anti-inflammatory effects of pentoxifylline in claudication. Am J Med Sci (1991) 0.81
Changes in cerebrospinal fluid IgG and apolipoprotein E indices in patients with multiple sclerosis during demyelination and remyelination. Clin Chem (1987) 0.81
Proposals from the IFCC Committee on Standardization of Markers of Cardiac Damage (C-SMCD): strategies and concepts on standardization of cardiac marker assays. Scand J Clin Lab Invest Suppl (1999) 0.80
Lecithin cholesterol acyltransferase in human cerebrospinal fluid: reduced level in patients with multiple sclerosis and evidence of direct synthesis in the brain. Int J Clin Lab Res (1992) 0.80
Creatine kinase and its CK-MB isoenzyme: the conventional marker for the diagnosis of acute myocardial infarction. J Emerg Med (1999) 0.79
Bioavailability of digoxin capsules and tablets: effect of coadministered fluid volume. J Pharm Sci (1984) 0.79
Cerebrospinal fluid and plasma apolipoproteins in patients with multiple sclerosis. Ann Clin Lab Sci (1988) 0.78
Analytical performance and clinical utility of a sensitive immunoassay for determination of human cardiac troponin I. Clin Biochem (1997) 0.78
Biochemical markers in suspected acute myocardial infarction: the need for early assessment. Clin Chem (1995) 0.78
Multicenter study of Abbott AxSYM Digoxin II assay and comparison with 6 methods for susceptibility to digoxin-like immunoreactive factors. Clin Chem (1997) 0.77
Evidence based approach to practice guides and decision thresholds for cardiac markers. Scand J Clin Lab Invest Suppl (1999) 0.77
Proposals from IFCC Committee on Standardization of Markers of Cardiac Damage (C-SMCD): recommendations on use of biochemical markers of cardiac damage in acute coronary syndromes. Scand J Clin Lab Invest Suppl (1999) 0.77
Assessment of coronary reperfusion after thrombolysis with a model combining myoglobin, creatine kinase-MB, and clinical variables. TAMI-7 Study Group. Thrombolysis and Angioplasty in Myocardial Infarction-7. Circulation (1997) 0.77
Eight compact analysis systems evaluated for measuring total cholesterol. Clin Chem (1994) 0.76
Oxygen transport and cardiovascular effects of resuscitation from severe hemorrhagic shock using hemoglobin solutions. Crit Care Med (1995) 0.76
A routine method for the determination of digoxin in urine by radioimmunoassay. Clin Chim Acta (1982) 0.75
Utilization of multiple imperfect assessments of the dependent variable in a logistic regression analysis. Stat Med (2000) 0.75
Characteristics of a 20-minute whole blood rapid assay for cardiac troponin T. Clin Biochem (1997) 0.75
CSF TRAP: a procedure to improve laboratory testing with myelography. Neurosurgery (1989) 0.75
Creatine kinase MM and MB isoforms in patients receiving thrombolytic therapy and acute angiography. TAMI Study Group. Clin Chem (1995) 0.75
Roche and Abbott carcinoembryonic antigen assays compared. Clin Chem (1982) 0.75
Performance characteristics of the creatine kinase-MB mass assay on the Vitros ECi analyzer. Clin Biochem (1999) 0.75
Use of heparinized samples for salicylate determination with the DuPont aca validated. Clin Chem (1983) 0.75
Simplified fluorometry of total metanephrines in urine. Clin Chem (1982) 0.75
Determination of the falloff constant (k(f)) from modeling biochemical marker release: a new variable for discriminating therapies. Cardiovasc Toxicol (2001) 0.75
Standardization of creatine kinase-MB (CK-MB) mass assays: the use of recombinant CK-MB as a reference material. Clin Chem (1999) 0.75
Performance characteristics of a new myoglobin microparticle enzyme immunoassay: a multicenter evaluation. Clin Biochem (2000) 0.75
Thyroid function testing evaluated on three immunoassay systems. J Clin Lab Anal (1995) 0.75
[The ways of harmonization of clinical laboratory measurement techniques]. Klin Lab Diagn (2013) 0.75
Production and characterization of monoclonal antibodies to human carbonic anhydrase III. Hybridoma (1998) 0.75
Increased lactate dehydrogenase isoenzyme 1 in serum and tumor tissue of a patient with small-cell carcinoma. Clin Chem (1986) 0.75
Issues in cerebrospinal fluid management. CSF Venereal Disease Research Laboratory testing. Am J Clin Pathol (1991) 0.75
Relationship between serum lactate and ionized calcium in open-heart surgery. Clin Chem (1986) 0.75
Abbott AxSYM Vancomycin II assay: multicenter evaluation and interference studies. Ther Drug Monit (1998) 0.75
Automated determination of apolipoprotein AI and apolipoprotein E in cerebrospinal fluid. Clin Chem (1986) 0.75
Multicenter evaluation of the Abbott AxSYM procainamide and N-acetylprocainamide assays: comparison with Abbott TDx/TDxFLx, Syva EMIT 2000, DuPont ACA, and HPLC methods. Clin Biochem (1998) 0.75
Establishment of a CSF bank. Neurology (1988) 0.75
Multisite study of a second generation whole blood rapid assay for cardiac troponin T. Ann Clin Biochem (1999) 0.75
Ratio of ST-segment and myoglobin slopes to estimate myocardial salvage during thrombolytic therapy for acute myocardial infarction. Am J Cardiol (1993) 0.75
Unacceptable potassium measurements. J Fam Pract (1991) 0.75
Results of dipstick tests, visual inspection, microscopic examination of urine sediment, and microbiological cultures of urine compared for simplifying urinalysis. Clin Chem (1985) 0.75
In vitro interference of the red cell substitute pyridoxalated hemoglobin-polyoxyethylene with blood compatibility, coagulation, and clinical chemistry testing. J Cardiothorac Vasc Anesth (1997) 0.75
Performance characteristics of a revised cardiac Troponin I assay for the Opus plus immunoassay system. Clin Biochem (2001) 0.75
Oligoclonal banding in cerebrospinal fluid assessed by electrophoresis on agarose after centrifugal sample concentration through a microconcentrator membrane. Clin Chem (1985) 0.75
Digoxin-like immunoreactivity eliminated from serum by centrifugal ultrafiltration before fluorescence polarization immunoassay of digoxin. Clin Chem (1987) 0.75
Lesion-directed administration of alteplase with intracoronary heparin in patients with unstable angina and coronary thrombus undergoing angioplasty. Cathet Cardiovasc Diagn (1996) 0.75
Management of cerebrospinal fluid. N C Med J (1990) 0.75